GlassScriptPhysician profile
Jonathan P Nass
NPI 1558587998
$856.15
in general payments reported to CMS, 2019-2025
13 companies · $31.28 in 2025
The $31.28 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $798 · 2020: $12.65 · 2022: $14.23 · 2025: $31.28.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $31.28.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $31.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $170.96 | 2019-2020 | |
| Abbvie INC. | $134.66 | 2019-2022 | |
| Janssen Biotech, INC. | $113.53 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $104.56 | 2019 | |
| Pfizer INC. | $86.21 | 2019 | |
| Janssen Scientific Affairs, LLC | $39.08 | 2019 | |
| Shire North American Group INC | $35.95 | 2019 | |
| Ironwood Pharmaceuticals, INC | $35.44 | 2019 | |
| Conmed Corporation | $31.28 | 2025 | |
| Intercept Pharmaceuticals, INC. | $31.19 | 2019 | |
| Merck Sharp & Dohme LLC | $26.94 | 2019 | |
| Gilead Sciences, INC. | $23.70 | 2019 | |
| Shionogi INC | $22.65 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Nass listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.